<sup>89</sup>Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NF<i>κ</i>B and JNK Signaling

<div>PET/CT imaging of tumor <sup>89</sup>Zr-PD-1 IgG uptake and effects of PMA stimulation. Representative maximum intensity projection images (a–c) and coronal (d–f) and transaxial PET images (g) of mice at baseline, with excess antibody blocking, and after PMA treatment at 6 days after intravenous <sup>89</sup>Zr-PD-1 IgG. Arrows indicate EL4 tumors.</div>

Molecular Imaging

fig5

Figure 5

Figure 5: <sup>89</sup>Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NF<i>κ</i>B and JNK Signaling 

Molecular Imaging

89Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NFκB and JNK Signaling

Figure 5

⁸⁹Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NFκB and JNK Signaling